What does UnitedHealth Group’s massive AI push mean for patients?
From a scan of its job openings, it would be easy to mistake UnitedHealth Group for Silicon Valley’s…
How the FDA’s stance on breakthrough AI is evolving
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Large AI scribe study finds modest time savings, inconsistent use
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Pharmalittle: Pharma delays Europe launches, Lilly, Biogen deals
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
Health care giants are trimming jobs, not driving employment growth
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
AI doctor startup Doctronic raises $40 million to fund rapid growth
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
AI Prognosis: A 2023 health AI bet that seems to be paying off
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health…
Pharma penalties for doctors’ kickbacks just a cost of doing business
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs…
Qualified Health raises $125 million to help hospitals manage AI
It was 2023. ChatGPT had been released less than five months earlier. Justin Norden was sitting around a…
FDA telehealth crackdown highlights role of national doctor networks
The Food and Drug Administration is cracking down on telehealth companies’ marketing of compounded versions of weight loss…
Health AI agents are here, but what about the validation?
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…